fbpx

Equity Research of
Nordic Growth Companies

Written by 10:00 Analys, Research

MELTRON: Bright outlook with triggers ahead

With a difficult fiscal year now in the books, Meltron is looking to start over with an increased focus on cost efficiency, direct sales and building a wider distribution network throughout Northern Europe. Combined with the high potential deals awaiting in the Middle East, and Oman in particular, there are several triggers to drive a revaluation of the share from today’s levels. With the proceeds from the rights issue of SEK 16m at SEK 0,10 per share, we continue to find support for a fair value of SEK 0,29-0,39 per share in 12-24 months.


Andreas Eriksson | 2022-09-29 10:00 

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and Emergers is not subject to any prohibition on dealing ahead of the dissemination of investment research. This research does not constitute investment advice and is not a solicitation to buy shares. For more information, please refer to disclaimer.  


Cost efficiency and diversification highlights in H1’22

As Meltron close the books for the fiscal year 21/22 (July-June), we can conclude that it has been a tough one. Sales did rebound a bit during calendar H1’22 amounting to SEK 3.6m, but combined with the disappointing calendar H2’21, full year Sales landed at SEK 5m, compared to our forecast of SEK 7m. We do however note that the cost efficiency program launched with the appointment of CEO Stefan Kåla has gained traction, where costs decreased by 26% in calendar H1’22 compared to H2’21. The company has also signaled even further cost reduction through better purchase of components as well as outsourcing production, which should facilitate reaching breakeven at lower sales than we earlier anticipated. Meltron is in the midst of building a distribution network consisting of wholesalers and lightning experts throughout Finland and northern Europe, where profound discussions are expected to be finalized shortly. This strategy combined with direct sales to Finnish industry clients whom Meltron has long relationships with, will hopefully get sales going, without being too dependent on the higher deal values in the Middle East.

Protracted high-value negotiations in Oman

While discussions with customers in Oman, where deal values are considerably higher than in northern Europe, has taken longer than expected, Meltron has focused on what they can control and managed to deliver on several orders from larger industrial clients in Finland. This is important for stable future cash flows, to not just rely on a few big orders. We do however still see the considerable potential in Oman and other countries in the Middle East, where there are major infrastructural projects ongoing and Meltron stands ready to deliver on tenders to both football stadiums and large infrastructure projects included in the MOU signed in February. The initial deal value of about SEK 20m is associated with some additional investments in the area, but would give Meltron a local proof of work and a storefront to more easily lock in additional deals.

Several triggers to drive a revaluation

To reach neutral cashflow we estimate that Sales are required to reach at least SEK 45m at today’s OPEX around SEK 19m, meaning that with the smaller, but recurring orders from Finnish industry customers (deals around SEK 0,6m) Meltron needs to significantly increase the pace of customer acquisition. We do however still see high potential both in the Middle East as well as the cooperation with global giant Huawei. The latter was announced in late September 2021, and is still yet to deliver any firm deals. If order pace increases from Finnish and European customers and as we get more details regarding Oman, we expect to re-evaluate our rather defensive WACC of 30% which combined with a target multiple of 1.8x Sales 23/24E support a fair value of SEK 0,29 – 0,39 per share in 12-24 months, including the upcoming rights issue of SEK 16m.

DISCLAIMER

GENERAL DISCLAIMER AND COPYRIGHT

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research does not constitute investment advice and is not a solicitation to buy shares. Information provided here or on Emergers’ website emergers.se is not intended to be financial advice. This research shall not be construed as a recommendation or solicitation to invest in the companies described. Emergers cannot be held liable for either direct or indirect damages caused by decisions made on the basis of information in this analysis. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

This material is not intended to be financial advice. This material has been commissioned by the Company in question and prepared and issued by Emergers, in consideration of a fee payable by the Company. Emergers standard fees are SEK 240,000 pa for the production and broad dissemination of a detailed note following by regular update notes. Fees are paid upfront in cash without recourse. Emergers may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained herein represent those of the research analyst at Emergers at the time of publication. The company has been given the opportunity to influence factual statements before publication, but forecasts, conclusions and valuation reasoning are Emergers’ own. Forward-looking information or statements contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Emergers shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained in this material.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Emergers’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in this material may not be eligible for sale in all jurisdictions or to certain categories of investors. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

Investment in securities mentioned: Emergers has a restrictive policy relating to personal dealing and conflicts of interest. Emergers does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Emergers may have a position in any or related securities mentioned in this report, subject to Emergers’ policies on personal dealing and conflicts of interest.

Copyright: Copyright 2021 Incirrata AB (Emergers)

United Kingdom
This document is prepared and provided by Emergers for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the ”FPO”) (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States
Emergers relies upon the ”publishers’ exclusion” from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Emergers does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Be first to read new research on growth stocks